BTIG on United Therapeutics Corp. (UTHR): 'We believe Yutrepia likely sees positive readthrough from this data'
May 6, 2026 1:20 PM
BTIG analyst Julian Harrison reiterated a Neutral rating and {REMOVEPT} price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
